45 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01241 | Aurein 2.1 | GLLDIVKKVVGAFGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not found | Not found | Not found |
| dbacp01242 | Aurein 2.1 | GLLDIVKKVVGAFGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01244 | Aurein 2.2 | GLFDIVKKVVGALGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01246 | Aurein 2.3 | GLFDIVKKVVGAIGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01248 | Aurein 2.4 | GLFDIVKKVVGTLAGL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01249 | Aurein 2.5 | GLFDIVKKVVGAFGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01250 | Aurein 2.6 | GLFDIAKKVIGVIGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01251 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10-100 µM |
| dbacp01252 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10 µM |
| dbacp01253 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01254 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01255 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10-100 µM |
| dbacp01256 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10-100 µM |
| dbacp01257 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10-100 µM |
| dbacp01258 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10-100 µM |
| dbacp01259 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01260 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10-100 µM |
| dbacp01261 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10 µM |
| dbacp01262 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01263 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01264 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10-100 µM |
| dbacp01265 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10-100 µM |
| dbacp01266 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10-100 µM |
| dbacp01267 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10-100 µM |
| dbacp01268 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01269 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01270 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10 µM |
| dbacp01271 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10 µM |
| dbacp01272 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01273 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10-100 µM |
| dbacp01274 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10 µM |
| dbacp01275 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10 µM |
| dbacp01276 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10 µM |
| dbacp01277 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10 µM |
| dbacp01278 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01279 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01280 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10 µM |
| dbacp01281 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10-100 µM |
| dbacp01282 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01283 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01284 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10 µM |
| dbacp01285 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10 µM |
| dbacp01286 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10 µM |
| dbacp01287 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10 µM |
| dbacp01288 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |